Teliso-V (telisotuzumab vedotin) is pitching to become the first targeted cancer treatment for people with non-small cell lung cancer (NSCLC) whose tumours overexpress c-Met. The c-Met protein ...

Today will be a largely cloudy day, and it will be mainly dry to start. In the afternoon, there will be an increased chance of a shower in spots. Less mild than yesterday. Tonight This evening ...

After hours: March 21 at 7:53:41 PM EDT Loading Chart for MET ...

After hours: March 20 at 4:05:10 PM EDT Loading Chart for MET-PE ...

Bonus May 10, 2018 May 12, 2018 Mar 19, 2018 Bonus Ratio: 1 share(s) for every 20 shares held Bonus Nov 10, 2017 Nov 13, 2017 Jun 12, 2017 Bonus Ratio: 1 share(s) for every 20 shares held Gala Global ...

GoodReturns is your trusted source for the latest financial news, investment insights, and expert guidance. Stay updated and make informed decisions with our comprehensive updates.

GoodReturns is your trusted source for the latest financial news, investment insights, and expert guidance. Stay updated and make informed decisions with our comprehensive updates.